Comparison of brain atrophy measures for clinical use in multiple sclerosis

Loredana Storelli; Maria A. Rocca; Elisabetta Pagani; W. van Hecke; Nicola De Stefano; Àlex Rovira; Jaume Sastre‐Garriga; Jackie Palace; Massimo Filippi

Related publications

Article2008

Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis

D. R. Altmann, Bas Jasperse, Frederik Barkhof, K. Beckmann, Massimo Filippi, Ludwig Kappos, P. D. Molyneux, CH Polman, Carlo Pozzilli, Alan J. Thompson, K. Wagner, Tarek Yousry, D. H. Miller, Euspms Mri SubStudy

Article2018

Comparison of Methods for Whole-Brain and Grey Matter Atrophy Assessment in Multiple Sclerosis (S6.006)

Loredana Storelli, Maria A. Rocca, Elisabetta Pagani, Wim Van Hecke, Mark A. Horsfield, Nicola De Stefano, Àlex Rovira, Jaume Sastre‐Garriga, Jacqueline Palace, Diana M. Sima, Dirk Smeets, Massimo Filippi

Article2003

Interventions for the Prevention of Brain Atrophy in Multiple Sclerosis

Marco Rovaris, Massimo Filippi

Article2020

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Jaume Sastre‐Garriga, Deborah Pareto, Marco Battaglini, Maria A. Rocca, Olga Ciccarelli, Christian Enzinger, Jens Wuerfel, Maria Pia Sormani, Frederik Barkhof, Tarek Yousry, Nicola De Stefano, Mar Tintoré, Massimo Filippi, Claudio Gasperini, Ludwig Kappos, Jordi Río, Jette Lautrup Frederiksen, Jackie Palace, Hugo Vrenken, Xavier Montalbán, Àlex Rovira

Article2005

Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.

Elisabetta Pagani, Maria A. Rocca, Antonio Gallo, Marco Rovaris, Vittorio Martinelli, Giancarlo Comi, Massimo Filippi